{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:27:18Z","timestamp":1793698038614,"version":"4.5.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Qassim University and the Saudi Ministry of Education, with additional support from the Saudi Arabian Cultural Mission (SACM) in Australia","id":[{"id":"https:\/\/ror.org\/044weyr28","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The University of Sydney","id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Acute exacerbations of chronic obstructive pulmonary disease (COPD) are a common cause of antibiotic use and hospital admissions. Although antimicrobial stewardship (AMS) programs are well established, the specific contribution of pharmacists to COPD-related antimicrobial decision-making remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To explore hospital pharmacists\u2019 perspectives on their roles, responsibilities, and application of AMS principles in the management of hospitalised patients with COPD exacerbations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We conducted a qualitative study using semi-structured interviews with hospital pharmacists involved in COPD care and\/or AMS activities at two public tertiary hospitals in Sydney, Australia. Our research was informed by a constructivist epistemology and critical realist orientation. Interviews were conducted via Zoom, audio-recorded, transcribed verbatim, and analysed inductively using reflexive thematic analysis. Recruitment continued until data saturation was reached.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventeen pharmacists participated and three themes were identified. First, pharmacists described AMS as being a core component of their professional role, including reviewing antimicrobial indication, dose, duration, and spectrum, and promoting appropriate antimicrobial use. However, their involvement typically occurred after initial prescribing, with greater influence on treatment duration than agent selection. Second, organisational and structural factors shaped their scope of practice, including workload pressures, hierarchical prescribing cultures, limited prescribing authority, and electronic system challenges, particularly during transitions of care. Third, pharmacists described patient-centred roles alongside stewardship, including counselling on antibiotic use and discharge medicines, as well as support for inhaler technique, vaccination, and smoking cessation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hospital pharmacists view AMS as a core part of managing COPD exacerbations. Their contributions include antimicrobial review, interdisciplinary communication, and patient education, but their involvement is often advisory and constrained by organisational structures, workload, and prescribing hierarchies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02217-w","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:59:02Z","timestamp":1789477142000},"page":"2394-2402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial stewardship in acute exacerbations of COPD: a qualitative study of hospital pharmacists\u2019 perspectives"],"prefix":"10.1007","volume":"48","author":[{"given":"Abdulaziz","family":"Alrashdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Gun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandana","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"9","key":"2217_CR1","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","volume":"17","author":"D Baur","year":"2017","unstructured":"Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(9):990\u20131001. https:\/\/doi.org\/10.1016\/S1473-3099(17)30325-0.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"2217_CR2","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1128\/AAC.00825-16","volume":"60","author":"S Karanika","year":"2016","unstructured":"Karanika S, Paudel S, Grigoras C, et al. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother. 2016;60(8):4840\u201352. https:\/\/doi.org\/10.1128\/AAC.00825-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"2217_CR3","unstructured":"World Health Organization. Promoting antimicrobial stewardship to tackle antimicrobial resistance. www.who.int. 2021. https:\/\/www.who.int\/europe\/activities\/promoting-antimicrobial-stewardship-to-tackle-antimicrobial-resistance. Accessed 10 Apr 2026."},{"issue":"21","key":"2217_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/ajhp\/zxad164","volume":"80","author":"CD Collins","year":"2023","unstructured":"Collins CD, Dumkow LE, Kufel WD, et al. ASHP\/SIDP joint statement on the pharmacist\u2019s role in antimicrobial stewardship. Am J Health Syst Pharm. 2023;80(21):1577\u201381. https:\/\/doi.org\/10.1093\/ajhp\/zxad164.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"2217_CR5","doi-asserted-by":"publisher","first-page":"9501","DOI":"10.1038\/s41598-022-13246-6","volume":"12","author":"MR Cantudo-Cuenca","year":"2022","unstructured":"Cantudo-Cuenca MR, Jim\u00e9nez-Morales A, Mart\u00ednez-de la Plata JE. Pharmacist-led antimicrobial stewardship programme in a small hospital without infectious diseases physicians. Sci Rep. 2022;12(1):9501. https:\/\/doi.org\/10.1038\/s41598-022-13246-6.","journal-title":"Sci Rep"},{"key":"2217_CR6","doi-asserted-by":"publisher","first-page":"107306","DOI":"10.1016\/j.ijid.2024.107306","volume":"151","author":"V Nampoothiri","year":"2025","unstructured":"Nampoothiri V, Hisham M, Mbamalu O, et al. Evolution of pharmacist roles in antimicrobial stewardship: a 20-year systematic review. Int J Infect Dis. 2025;151:107306. https:\/\/doi.org\/10.1016\/j.ijid.2024.107306.","journal-title":"Int J Infect Dis"},{"issue":"8","key":"2217_CR7","doi-asserted-by":"publisher","first-page":"102753","DOI":"10.1016\/j.jiac.2025.102753","volume":"31","author":"Y Krishnamoorthy","year":"2025","unstructured":"Krishnamoorthy Y, Govindan D, Karunakaran M, et al. Global impact of antimicrobial stewardship programs in healthcare: an umbrella review of effectiveness, cost-efficiency, and implementation strategies. J Infect Chemother. 2025;31(8):102753. https:\/\/doi.org\/10.1016\/j.jiac.2025.102753.","journal-title":"J Infect Chemother"},{"issue":"4","key":"2217_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1445-5994.2011.02475.x","volume":"42","author":"JJ Pretto","year":"2012","unstructured":"Pretto JJ, McDonald VM, Wark PA, et al. Multicentre audit of inpatient management of acute exacerbations of chronic obstructive pulmonary disease: comparison with clinical guidelines. Intern Med J. 2012;42(4):380\u20137. https:\/\/doi.org\/10.1111\/j.1445-5994.2011.02475.x.","journal-title":"Intern Med J"},{"issue":"3","key":"2217_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/jcpt.12514","volume":"42","author":"DJ Brownridge","year":"2017","unstructured":"Brownridge DJ, Zaidi STR. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital. J Clin Pharm Ther. 2017;42(3):301\u20135. https:\/\/doi.org\/10.1111\/jcpt.12514.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"2217_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1465-9921-9-62","volume":"9","author":"RCM Jones","year":"2008","unstructured":"Jones RCM, Dickson-Spillmann M, Mather MJC, et al. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir Res. 2008;9(1):62. https:\/\/doi.org\/10.1186\/1465-9921-9-62.","journal-title":"Respir Res"},{"key":"2217_CR11","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2026 Report. Fontana: Global Initiative for Chronic Obstructive Lung Disease; 2026. Available from: https:\/\/goldcopd.org\/2026-gold-report-and-pocket-guide\/. Accessed 10 Feb 2026."},{"key":"2217_CR12","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report. Fontana: Global Initiative for Chronic Obstructive Lung Disease; 2025. Available from: https:\/\/goldcopd.org\/2025-gold-report\/. Accessed 10 Feb 2026."},{"key":"2217_CR13","unstructured":"World Health Organization (WHO). Chronic obstructive pulmonary disease (COPD). World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd). Accessed 20 Feb 2026."},{"issue":"22","key":"2217_CR14","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMRA0800353","volume":"359","author":"S Sethi","year":"2008","unstructured":"Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359(22):2355\u201365. https:\/\/doi.org\/10.1056\/NEJMRA0800353.","journal-title":"N Engl J Med"},{"issue":"6","key":"2217_CR15","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/resp.12099","volume":"18","author":"PAB Wark","year":"2013","unstructured":"Wark PAB, Tooze M, Powell H, et al. Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology. 2013;18(6):996\u20131002. https:\/\/doi.org\/10.1111\/resp.12099.","journal-title":"Respirology"},{"issue":"10","key":"2217_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/IMJ.13213","volume":"46","author":"E Biancardi","year":"2016","unstructured":"Biancardi E, Fennell M, Rawlinson W, et al. Viruses are frequently present as the infecting agent in acute exacerbations of chronic obstructive pulmonary disease in patients presenting to hospital. Intern Med J. 2016;46(10):1160\u20135. https:\/\/doi.org\/10.1111\/IMJ.13213.","journal-title":"Intern Med J"},{"issue":"10","key":"2217_CR17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.5694\/mja2.51708","volume":"217","author":"E Dabscheck","year":"2022","unstructured":"Dabscheck E, George J, Hermann K, et al. COPD-X Australian guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2022 update. Med J Aust. 2022;217(10):S1\u201324. https:\/\/doi.org\/10.5694\/mja2.51708.","journal-title":"Med J Aust"},{"issue":"3","key":"2217_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.sapharm.2017.03.051","volume":"14","author":"E Rosenfeld","year":"2018","unstructured":"Rosenfeld E, Kinney S, Weiner C, et al. Interdisciplinary medication decision making by pharmacists in pediatric hospital settings: an ethnographic study. Res Social Adm Pharm. 2018;14(3):269\u201378. https:\/\/doi.org\/10.1016\/j.sapharm.2017.03.051.","journal-title":"Res Social Adm Pharm"},{"key":"2217_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-025-01515-8","volume":"14","author":"S Ananth","year":"2025","unstructured":"Ananth S, Adeoti AO, Ray A, et al. Healthcare worker views on antimicrobial resistance in chronic respiratory disease. Antimicrob Resist Infect Control. 2025;14:1. https:\/\/doi.org\/10.1186\/s13756-025-01515-8.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"6","key":"2217_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"2217_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1108\/QROM-06-2019-1778","volume":"15","author":"F Bogna","year":"2020","unstructured":"Bogna F, Raineri A, Dell G. Critical realism and constructivism: merging research paradigms for a deeper qualitative study. Qual Res Organ Manag. 2020;15(4):461\u201384. https:\/\/doi.org\/10.1108\/QROM-06-2019-1778.","journal-title":"Qual Res Organ Manag"},{"key":"2217_CR22","unstructured":"Zoom cloud meetings. Version 5.17. San Jose: Zoom Video Communications, Inc.; 2025. Available from: https:\/\/www.zoom.com."},{"key":"2217_CR23","unstructured":"NVivo. Denver: Lumivero; 2025. Available from: https:\/\/lumivero.com\/products\/nvivo\/."},{"issue":"9","key":"2217_CR24","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.46743\/2160-3715\/2015.2281","volume":"20","author":"PI Fusch","year":"2015","unstructured":"Fusch PI, Ness LR. Are we there yet? Data saturation in qualitative research. Qual Rep. 2015;20(9):1408\u201316. https:\/\/doi.org\/10.46743\/2160-3715\/2015.2281.","journal-title":"Qual Rep"},{"issue":"4","key":"2217_CR25","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders B, Sim J, Kingstone T, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893\u2013907. https:\/\/doi.org\/10.1007\/s11135-017-0574-8.","journal-title":"Qual Quant"},{"issue":"2","key":"2217_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"issue":"4","key":"2217_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jhin.2017.05.001","volume":"96","author":"J Broom","year":"2017","unstructured":"Broom J, Broom A, Kirby E. How do hospital respiratory clinicians perceive antimicrobial stewardship (AMS)? A qualitative study highlighting barriers to AMS in respiratory medicine. J Hosp Infect. 2017;96(4):316\u201322. https:\/\/doi.org\/10.1016\/j.jhin.2017.05.001.","journal-title":"J Hosp Infect"},{"key":"2217_CR28","volume-title":"How good people make tough choices: resolving the dilemmas of ethical living","author":"RM Kidder","year":"2003","unstructured":"Kidder RM. How good people make tough choices: resolving the dilemmas of ethical living. New York: Quill; 2003."},{"key":"2217_CR29","volume-title":"Principles of Biomedical Ethics","author":"TL Beauchamp","year":"2019","unstructured":"Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 7th ed. New York: Oxford University Press; 2019.","edition":"7"},{"issue":"3","key":"2217_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/1715163521999417","volume":"154","author":"JHC Wu","year":"2021","unstructured":"Wu JHC, Khalid F, Langford BJ, et al. Community pharmacist prescribing of antimicrobials: a systematic review from an antimicrobial stewardship perspective. Can Pharm J. 2021;154(3):179\u201392. https:\/\/doi.org\/10.1177\/1715163521999417.","journal-title":"Can Pharm J"},{"key":"2217_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.sapharm.2025.09.006","volume":"22","author":"H Amer","year":"2026","unstructured":"Amer H, Marotti S, Widagdo I, et al. Collaborative pharmacist prescribing models in Australian hospitals: a scoping study. Res Social Adm Pharm. 2026;22:185\u201394. https:\/\/doi.org\/10.1016\/j.sapharm.2025.09.006.","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"2217_CR32","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.4212\/cjhp.3421","volume":"76","author":"G Iovino","year":"2023","unstructured":"Iovino G, Nadeau L. Effect of pharmacist-initiated interventions on duration of antibiotic therapy for acute exacerbation of chronic obstructive pulmonary disease and community-acquired pneumonia. Can J Hosp Pharm. 2023;76(4):3421. https:\/\/doi.org\/10.4212\/cjhp.3421.","journal-title":"Can J Hosp Pharm"},{"issue":"11","key":"2217_CR33","doi-asserted-by":"publisher","first-page":"e008326","DOI":"10.1136\/bmjopen-2015-008326","volume":"5","author":"A Broom","year":"2015","unstructured":"Broom A, Broom J, Kirby E, et al. What role do pharmacists play in mediating antibiotic use in hospitals? A qualitative study. BMJ Open. 2015;5(11):e008326. https:\/\/doi.org\/10.1136\/bmjopen-2015-008326.","journal-title":"BMJ Open"},{"issue":"3","key":"2217_CR34","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.18549\/PharmPract.2020.3.2078","volume":"18","author":"H Rakvaag","year":"2020","unstructured":"Rakvaag H, S\u00f8reide GE, Meland E, et al. Complementing or conflicting? How pharmacists and physicians position the community pharmacist. Pharm Pract (Granada). 2020;18(3):2078. https:\/\/doi.org\/10.18549\/PharmPract.2020.3.2078.","journal-title":"Pharm Pract (Granada)"},{"key":"2217_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2147\/COPD.S288792","volume":"16","author":"M Fathima","year":"2021","unstructured":"Fathima M, Bawa Z, Mitchell B, et al. COPD management in community pharmacy results in improved inhaler use, immunization rate, COPD action plan ownership, COPD knowledge, and reductions in exacerbation rates. Int J Chron Obstruct Pulmon Dis. 2021;16:519\u201333. https:\/\/doi.org\/10.2147\/COPD.S288792.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"4","key":"2217_CR36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/bmjqs-2017-007087","volume":"27","author":"D McNab","year":"2018","unstructured":"McNab D, Bowie P, Ross A, et al. Systematic review and meta-analysis of the effectiveness of pharmacist-led medication reconciliation in the community after hospital discharge. BMJ Qual Saf. 2018;27(4):308\u201320. https:\/\/doi.org\/10.1136\/bmjqs-2017-007087.","journal-title":"BMJ Qual Saf"},{"issue":"1","key":"2217_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.japh.2022.08.005","volume":"63","author":"L Kerstenetzky-Brenny","year":"2003","unstructured":"Kerstenetzky-Brenny L, Adamsick ML, Lauscher RL, et al. Pharmacist discharge summary: impact of inpatient to community pharmacist handoff at hospital discharge. J Am Pharm Assoc. 2003;63(1):198-203.e4. https:\/\/doi.org\/10.1016\/j.japh.2022.08.005.","journal-title":"J Am Pharm Assoc"},{"key":"2217_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12883-025-04474-0","volume":"25","author":"Y Fukuda","year":"2025","unstructured":"Fukuda Y, Ito R, Kakihana M, et al. Effects of hospital pharmacist\u2013community pharmacist collaboration on solving pharmacotherapy problems in stroke patients with post-discharge transitions: non-randomized comparative study. BMC Neurol. 2025;25:459. https:\/\/doi.org\/10.1186\/s12883-025-04474-0.","journal-title":"BMC Neurol"},{"issue":"4","key":"2217_CR39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/15412555.2020.1787369","volume":"17","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Li S, Zhou W, et al. Risk of pneumonia with different inhaled corticosteroids in COPD patients: a meta-analysis. COPD. 2020;17(4):462\u20139. https:\/\/doi.org\/10.1080\/15412555.2020.1787369.","journal-title":"COPD"},{"key":"2217_CR40","unstructured":"Yang IA, George J, McDonald CF et al. The COPD-X Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2025. Version 2.78. Lung Foundation Australia; 2025. Available from: https:\/\/copdx.org.au\/copd-x-plan\/. Accessed 22 Mar 2026."},{"issue":"3","key":"2217_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2213-2600(13)70038-9","volume":"1","author":"DJ Serisier","year":"2013","unstructured":"Serisier DJ. Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases. Lancet Respir Med. 2013;1(3):262\u201374. https:\/\/doi.org\/10.1016\/S2213-2600(13)70038-9.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"2217_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1753465816682677","volume":"11","author":"S Qiu","year":"2017","unstructured":"Qiu S, Zhong X. Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2017;11(3):147\u201355. https:\/\/doi.org\/10.1177\/1753465816682677.","journal-title":"Ther Adv Respir Dis"},{"issue":"6","key":"2217_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5152\/TurkThoracJ.2020.19074","volume":"21","author":"Y Varol","year":"2020","unstructured":"Varol Y, Karakurt Z, \u00c7\u0131rak AK, et al. Inappropriate utilization of antibiotics in COPD exacerbations. Turk Thorac J. 2020;21(6):397\u2013403. https:\/\/doi.org\/10.5152\/TurkThoracJ.2020.19074.","journal-title":"Turk Thorac J"},{"issue":"5","key":"2217_CR44","doi-asserted-by":"publisher","first-page":"e2211331","DOI":"10.1001\/jamanetworkopen.2022.11331","volume":"5","author":"NJ Mercuro","year":"2022","unstructured":"Mercuro NJ, Medler CJ, Kenney RM, et al. Pharmacist-driven transitions of care practice model for prescribing oral antimicrobials at hospital discharge. JAMA Netw Open. 2022;5(5):e2211331. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.11331.","journal-title":"JAMA Netw Open"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02217-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02217-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02217-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:39:12Z","timestamp":1793695152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02217-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2217"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02217-w","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"13 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Human Research Ethics Committee at Western Sydney Local Health District (approval number: 2024\/ETH01617).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}